Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Viemed HealthcareVMD +0.33%93 Graham Number is $4.30 as of Mar. 2026, which is 119% above its 10-year median of 1.96. GuruFocus rates VMD with a GF Score™ of 93/100 and a GF Value™ of $10.95 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 401 Medical Devices & Instruments companies, Viemed Healthcare ranks worse than 72.82% on this metric.
Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.
As of today (2026-07-19), the stock price of Viemed Healthcare is $12.15. Viemed Healthcare's graham number for the quarter that ended in Mar. 2026 was $4.30. Therefore, Viemed Healthcare's Price to Graham Number ratio for today is 2.82.
The historical rank and industry rank for Viemed Healthcare's Graham Number or its related term are showing as below:
VMD'
s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.11 Med: 1.96 Max: 3.32
Current: 2.83
During the past 10 years, the highest Price to Graham Number ratio of Viemed Healthcare was 3.32. The lowest was 1.11. And the median was 1.96.
VMD's Price-to-Graham-Number is ranked worse than 72.82% of 401
companies
in the Medical Devices & Instruments industry
Industry Median: 1.74
vs VMD: 2.83
Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.
Viemed Healthcare (NAS:VMD) Graham Number Explanation
Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:
Current price should not be more than 15 times average earnings of the past three years.
Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)
Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.
In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.
Viemed Healthcare's Price to Graham number Ratio for today is calculated as
Price to Graham number
=
Share Price (Today)
/
Graham number (Q: Mar. 2026 )
=
12.15
/
4.30
=
2.82
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Please keep these in mind:
1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.
Viemed Healthcare Graham Number Related Terms
Viemed Healthcare Graham Number Historical Data
* Premium members only.
The historical data trend for Viemed Healthcare's Graham Number can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Viemed Healthcare's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viemed Healthcare Price-to-Graham-Number vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Viemed Healthcare's Price-to-Graham-Number distribution charts can be found below:
* The bar in red indicates where Viemed Healthcare's Price-to-Graham-Number falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viemed Healthcare (VMD) has a Graham Number of $4.30 as of Mar. 2026. The Graham Number values a company based on its per-share earnings and book value. View historical data on Viemed Healthcare and its competitors. This is 119% above median its historical median of 1.96. Over the past decade, Viemed Healthcare's Graham Number has ranged from 1.11 to 3.32. According to the industry distribution chart, Viemed Healthcare ranks #292 out of 401 companies in the Medical Devices & Instruments industry, placing it in the top 72.8%.
Is Viemed Healthcare's Graham Number too high?
Viemed Healthcare's current Graham Number of $4.30 is 119% above median its 10-year median of 1.96. Over the past 10 years, this metric has ranged from a low of 1.11 to a high of 3.32. The Medical Devices & Instruments industry median Graham Number is 1.74. Viemed Healthcare's value of $4.30 is 147.1% above this industry median. Based on the distribution chart, Viemed Healthcare ranks #292 out of 401 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Viemed Healthcare has a GF Score™ of 93/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viemed Healthcare's Graham Number compare to DCTH and VREX?
According to the Medical Devices & Instruments industry distribution chart, Viemed Healthcare ranks #292 out of 401 companies for Graham Number. This places Viemed Healthcare in the lower half of its industry. The industry median Graham Number is 1.74. Viemed Healthcare's value of $4.30 is 147.1% above this benchmark. Historically, Viemed Healthcare's own Graham Number has ranged from 1.11 to 3.32 over the past decade. While the company's 10-year median is 1.96 vs. the industry median of 1.74, Viemed Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Medical Devices & Instruments company?
The median Graham Number among Medical Devices & Instruments companies is 1.74, based on 401 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viemed Healthcare's current Graham Number of $4.30 is 147.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on Viemed Healthcare and its competitors. For the Medical Devices & Instruments industry, the median Graham Number is 1.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viemed Healthcare's current Graham Number is $4.30, which is 119% above median its own 10-year median of 1.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viemed Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Viemed Healthcare (VMD) is currently considered Modestly Overvalued. The stock's GF Value™ is $10.95, compared to a current price of $12.15 — trading 11% above its estimated fair value. The current Graham Number is $4.30, which is 119% above median its 10-year median of 1.96 and 147.1% above the Medical Devices & Instruments industry median of 1.74. Viemed Healthcare's overall GF Score™ is 93/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For Viemed Healthcare (VMD), the current Graham Number is $4.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viemed Healthcare (VMD) Overvalued in 2026?
Based on GuruFocus' analysis, Viemed Healthcare stock appears to be overvalued.
The current stock price of $12.15 is trading 11% above its estimated GF Value™ of $10.95.
GuruFocus considers Viemed Healthcare to be Modestly Overvalued.
Key valuation signals for VMD:
Graham Number: $4.30 (119% above median its 10-year median of 1.96)
GF Value™: $10.95 vs. price of $12.15 (11% above fair value)
Industry Position: 147.1% above the Medical Devices & Instruments median (#292 of 401)
No single metric tells the full story. See the VMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
93GF Score
Get the complete analysis for VMD
Graham Number is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VMD has been successfully added to your 
